Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2014 · 10-Q
Revenue$130.83K$130.83K−66.2% vs Q1 2013 Net Income-$1.08M-$1.08MN/M vs Q1 2013 EPS Diluted-$0.01-$0.01— vs Q1 2013 Gross Profit$103,129−66.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Free Cash Flowderived-$342N/M Margins · derivedGross margin78.8%−0.7 pt vs Q1 2013
Net margin-822.6%−808.5 pt vs Q1 2013
ended Mar 31, 2014 · filed May 14, 2014 · 44 d after period end